HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keita Togashi Selected Research

Keita Togashi Research Topics

Disease

23Neoplasms (Cancer)
04/2024 - 11/2017
10Glioblastoma (Glioblastoma Multiforme)
04/2024 - 11/2017
9Glioma (Gliomas)
04/2024 - 07/2019
6Ovarian Neoplasms (Ovarian Cancer)
06/2023 - 11/2017
6Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 11/2017
4Meningioma (Meningiomas)
07/2023 - 01/2021
4Lung Neoplasms (Lung Cancer)
10/2019 - 08/2018
3Parkinson Disease (Parkinson's Disease)
10/2022 - 11/2017
3Neoplasm Metastasis (Metastasis)
01/2021 - 09/2018
2Brain Neoplasms (Brain Tumor)
08/2023 - 07/2022
2Retinoblastoma (Glioblastoma, Retinal)
10/2022 - 09/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2020 - 08/2018
1Uveal melanoma
12/2023
1Polycythemia Vera
03/2023
1Breast Ductal Carcinoma
01/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Ductal Carcinoma
01/2021
1Hypertension (High Blood Pressure)
08/2020
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2020
1Macular Degeneration (Age-Related Maculopathy)
01/2020
1Schizophrenia (Dementia Praecox)
07/2019
1Vomiting
11/2017
1Nausea
11/2017

Drug/Important Bio-Agent (IBA)

11SurvivinIBA
04/2024 - 11/2017
73,9-bis((ethylthio)methyl)-K-252aIBA
12/2023 - 11/2017
6GemcitabineFDA Link
03/2022 - 11/2017
5osimertinibIBA
09/2021 - 07/2019
4Paclitaxel (Taxol)FDA LinkGeneric
06/2023 - 08/2018
4Phosphotransferases (Kinase)IBA
10/2022 - 11/2017
4ErbB Receptors (EGF Receptor)IBA
09/2021 - 08/2018
4Tyrosine Kinase InhibitorsIBA
09/2021 - 07/2019
3Proteins (Proteins, Gene)FDA Link
06/2023 - 03/2022
3Apoptosis Regulatory ProteinsIBA
12/2020 - 05/2019
3Antipsychotic Agents (Antipsychotics)IBA
09/2019 - 11/2017
3brexpiprazoleIBA
09/2019 - 05/2019
3bentamapimodIBA
02/2019 - 09/2018
2Cisplatin (Platino)FDA LinkGeneric
06/2023 - 11/2017
2Histone Deacetylase InhibitorsIBA
06/2023 - 03/2023
2Messenger RNA (mRNA)IBA
06/2023 - 10/2022
2domatinostatIBA
06/2023 - 07/2022
2JNK Mitogen-Activated Protein KinasesIBA
08/2022 - 12/2018
2navitoclaxIBA
03/2022 - 01/2021
2Indicators and Reagents (Reagents)IBA
08/2021 - 05/2019
2Serotonin (5 Hydroxytryptamine)IBA
07/2019 - 05/2019
2Dopamine (Intropin)FDA LinkGeneric
07/2019 - 05/2019
1Proto-Oncogene Proteins c-mdm2IBA
08/2023
1Transcription Factors (Transcription Factor)IBA
06/2023
1Histone Deacetylases (Histone Deacetylase)IBA
03/2023
1Temozolomide (Temodar)FDA LinkGeneric
03/2023
1givinostatIBA
03/2023
1Phospholipases (Phospholipase)IBA
08/2022
1EverolimusFDA Link
03/2022
1Therapeutic UsesIBA
03/2022
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2021
1Lurasidone HydrochlorideFDA Link
09/2021
1Keratin-7 (Cytokeratin 7)IBA
01/2021
1Keratins (Keratin)IBA
01/2021
1Deoxycytidine KinaseIBA
01/2021
1Equilibrative Nucleoside Transporter 1IBA
01/2021
1SenotherapeuticsIBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2020
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
12/2020
1Dual Specificity Phosphatase 1IBA
12/2020
1QuinazolinesIBA
08/2020
1Doxazosin (Cardura)FDA LinkGeneric
08/2020
1Verteporfin (Visudyne)FDA Link
01/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2019
1Spironolactone (Aldactone)FDA LinkGeneric
10/2019
1PotassiumIBA
10/2019
1DiureticsIBA
10/2019
1Epidermal Growth Factor (EGF)IBA
07/2019
1Aripiprazole (Abilify)FDA Link
05/2019
1Carboplatin (JM8)FDA LinkGeneric
12/2018
1Coloring Agents (Dyes)IBA
09/2018
1ConnexinsIBA
09/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2018
1Gefitinib (Iressa)FDA Link
08/2018
1Glucose (Dextrose)FDA LinkGeneric
08/2018
1Fluorouracil (Carac)FDA LinkGeneric
11/2017
1AntiemeticsIBA
11/2017
1Olanzapine (Zyprexa)FDA Link
11/2017

Therapy/Procedure

10Therapeutics
04/2024 - 11/2017
4Drug Therapy (Chemotherapy)
07/2023 - 11/2017
2Adjuvant Radiotherapy
01/2021 - 01/2021